🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

After moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, messages show dark colored parcels with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly significant health risks”.